Clover Health Investments(CLOV) - 2024 Q2 - Quarterly Results

Clover Health Reports Second Quarter 2024 Financial Results; Improves Full-Year Guidance on Strong Performance Total Revenue growth for the Second Quarter of 2024 of 11% year-over-year GAAP Net Income from Continuing Operations during the Second Quarter of 2024 of $7.2 million versus Second Quarter 2023 GAAP loss of$28.9 million Adjusted EBITDA profitability for the Second Quarter of 2024 of $36.2 million versus Second Quarter 2023 Adjusted EBITDA of$9.9 million Increases Full-Year 2024 guidance to Insura ...